Pluto Bioinformatics

GSE94919: Chemoprevention with COX2 and EGFR inhibition in FAP patients: mRNA signatures of duodenal neoplasia

Bulk RNA sequencing

RNA sequencing of duodenal polyps in FAP patients treated with plabebo or the drug combination, erlotinib + sulindac SOURCE: Don Delker (don.delker@hsc.utah.edu) - University of Utah